Indications and uses
prevents and treats nausea, vomiting, or dizziness due to motion sickness for other uses, consult your doctor
prevents and treats nausea, vomiting, or dizziness due to motion sickness for other uses, consult your doctor
adults & children 12 years and over: 2-4 caplets once daily children under 12 years: ask a doctor
Meclizine HCL 12.5 mg
Antiemetic
Ask a docotor before use if you have
Ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers
When using this product
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Ask a doctor before use if you have
Ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers
When using this prodcut
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
croscarmellose sodium, dicalcium phosphate, magnesium stearate, microcrystalline cellulose, silicon dioxide, stearic acid
call 516-341-0666, 8:30 am - 4:30 pm ET, Monday - Friday
TAMPER EVIDENT: DO NOT USE IF IMPRINTED SAFETY SEAL UNDER CAP IS BROKEN OR MISSING
Distributed by: Reliable 1 Laboratoires LLC, Valley Stream, NY 11580
NDC 69618-027-10
Meclizine HCL 12.5 mg
ANTIEMETIC
1000 CAPLETS
THIS PACKAGE FOR HOUSEHOLDS WITHOUT YOUNG CHILDREN
| Class | Version | Type | Effective |
|---|---|---|---|
| MECLIZINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| ac6963c4-31c6-325f-ee58-83a0a06597ad | Product name | 5 | 20221206 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 69618-027-01 | 2023-03-29 | C162847 | 48780-1 | f386c649-eb62-0266-e053-dadaa90a7c1a | Meclizine HCL 12.5 |
| 69618-027-10 | 2023-03-29 | C162847 | 48780-1 | f386c649-eb62-0266-e053-dadaa90a7c1a | Meclizine HCL 12.5 |
| 69618-027-01 | 2023-01-30 | C162847 | 48780-1 | f386c649-eb62-0266-e053-dadaa90a7c1a | Meclizine HCL 12.5 |
| 69618-027-10 | 2023-01-30 | C162847 | 48780-1 | f386c649-eb62-0266-e053-dadaa90a7c1a | Meclizine HCL 12.5 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69618-027-01 | Meclizine HCL 12.5 mg | 100 in 1 BOTTLE, PLASTIC | TABLET | 100 | 6 | |
| 69618-027-10 | Meclizine HCL 12.5 mg | 1000 in 1 BOTTLE, PLASTIC | TABLET | 1000 | 6 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 69618-027-01 | EA - Each | 69618-027 | e78a02a0-6dfa-432d-8cbc-ddf3e88d9637 | 1 | 2016-05-16 |
| 69618-027-10 | EA - Each | 69618-027 | 7ce7769a-4a4f-4fab-a44b-6e35d5806023 | 1 | 2016-05-16 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 69618-027 | 69618-027-01, 69618-027-10 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CROSCARMELLOSE SODIUM | M28OL1HH48 | IACT |
| MECLIZINE HYDROCHLORIDE | HDP7W44CIO | ACTIB |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| STEARIC ACID | 4ELV7Z65AP | IACT |
| SILICON DIOXIDE | ETJ7Z6XBU4 | IACT |
| CELLULOSE, MICROCRYSTALLINE | OP1R32D61U | IACT |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | L11K75P92J | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Meclizine HCL 12.5 mg | MECLIZINE HCL 12.5 MG | Reliable 1 Laboratories LLC | 32832b0f-0b38-27ce-e054-00144ff8d46c | 2025-01-15 | Warnings | 69618-027-10 69618-027-01 69618-027 69618002710 69618002701 2bc82d20-1473-46c7-e063-6394a90a0d44 32832b0f-0b38-27ce-e054-00144ff8d46c |
Adverse event summaries are temporarily unavailable. Other product information remains available.